SEC Filing Document

Company: BIOVENTRIX, INC.
Ticker: 
CIK: 1283259
Filing Type: S-1
Document Type: EX-99.3
Date Filed: 2026-02-12
Accession Number: 0001493152-26-006407
Exchange: 
SIC Code: 3841
SIC Description: Surgical & Medical Instruments & Apparatus
URL: https://www.sec.gov/Archives/edgar/data/1283259/000149315226006407/ex99-3.htm

Chunk 1 of 2
Word Count: 769
Character Count: 5129

Document Content:

be approved by the Board and as may be set forth in the Company’s Corporate Governance Guidelines among any other criteria the Committee shall deem appropriate. 3. The Committee shall, at least annually, review the performance of each current director and shall consider the results of such evaluation when determining whether or not to recommend the nomination of such director for an additional term. 4. The Committee shall consider potential director candidates recommended by stockholders in the same manner candidates are identified by the Committee, provided that such recommendation is made in accordance with the Company’s procedures for nomination of directors by stockholders as provided in the Company’s bylaws and proxy statement. appropriate circumstances, the Committee, in its discretion, shall consider and may recommend the removal of a director for cause, in accordance with the applicable law, provisions of the Company’s certificate of incorporation, bylaws and any Corporate Governance Guidelines.

6. The
Committee shall, at least annually, review the composition of the various Board Committees and, as appropriate, make recommendations
to the Board for Committee membership.

7. The
Committee shall oversee the implementation and monitoring of compliance with the Company’s Code of Business Conduct other than
with respect to matters involving auditing and accounting issues as more fully set forth in Section III, subsection S. of the Company’s
Audit Committee Charter.

8. The
Committee shall oversee the evaluation of the Board and its Committees in the Board’s annual review of its performance and will
make appropriate recommendations to improve performance.

9. The
Committee shall also evaluate and make recommendations with respect to Board size and compensation and practices regarding the succession
of directors, taking into consideration the following factors, among others:

(a)	the
strategy and business activities of the Company;

(b)	the
strengths, weaknesses and performance of the Company;

(c)	the
duties and activities of the Board;

(d)	the
experience, expertise, capabilities, and skills; and

(e)	the
diversity of the members of the Board including diversity of age, gender identity, nationality,
race, ethnicity and sexual orientation, both individually and collectively.

In accordance with any the Company’s Corporate Governance Guidelines as may from time to time be adopted by the Board, the Committee
shall consider, develop and recommend to the Board such policies and procedures with respect to the nomination of directors or other
corporate governance matters as may be required or required to be disclosed pursuant to any rules promulgated by the Securities and Exchange
Commission or otherwise considered to be desirable and appropriate in the discretion of the Committee.

11. The
Chair of the Committee shall discuss with the Compensation Committee of the Board the Company’s ability to recruit and retain highly
qualified and capable directors, taking into consideration the amount and type of compensation afforded to non-management directors at
other similarly situated companies.

accordance with the Company’s Corporate Governance Guidelines as may from time to time be adopted by the Board, the Chair of the
Committee shall be notified of a director’s intent to join another public company board prior to accepting such other position.
The Chair of the Committee will determine if any potential conflicts of interest or compliance concerns exist and will then provide this
information to the Committee for review and approval of the position. A director shall also notify the Chairman of the Board and the
Chair of the Committee if the director experiences a significant change in professional roles or responsibility and must tender his/her
resignation. The Committee will then make a recommendation to the Board regarding whether to accept or reject such resignation and the
Board may take action accepting or rejecting such resignation in its discretion.

13. The
Committee shall, at least annually, review the institutional affiliations of directors and management candidates for director positions
for purposes of the Board’s determination of director independence and for possible conflicts of interest.

14. The
Committee shall evaluate its own performance on an annual basis, including its compliance with this Charter, and provide the Board with
any recommendations for changes in procedures or policies governing the Committee. The Committee shall conduct such evaluation and review
in such manner as it deems appropriate.

15. The Committee shall periodically report to the Board on its findings and actions.

16. The
Committee shall review and reassess this Charter at least annually and submit any recommended changes to the Board for its consideration.

Delegation of Duties

fulfilling its responsibilities, the Committee shall be entitled to delegate any or all of its responsibilities to a subcommittee of
the Committee, to the extent consistent with the Company’s certificate of incorporation, bylaws and applicable law and SEC and
NASDAQ rules.